BMB Reports

Korean Society for Biochemistry and Molecular Biology (생화학분자생물학회)
권호 표지
DOI QR코드

DOI QR Code

NOD2 signaling pathway is involved in fibronectin fragment-induced pro-catabolic factor expressions in human articular chondrocytes

  • Hwang, Hyun Sook (Division of Rheumatology, Department of Internal Medicine, Hallym University Sacred Heart Hospital) ;
  • Lee, Mi Hyun (Division of Rheumatology, Department of Internal Medicine, Hallym University Sacred Heart Hospital) ;
  • Choi, Min Ha (Division of Rheumatology, Department of Internal Medicine, Hallym University Sacred Heart Hospital) ;
  • Kim, Hyun Ah (Division of Rheumatology, Department of Internal Medicine, Hallym University Sacred Heart Hospital)
  • Received : 2018.07.20
  • Accepted : 2018.09.20
  • Published : 2019.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

The nucleotide-binding and oligomerization domain (NOD) is an innate pattern recognition receptor that recognizes pathogen- and damage-associated molecular patterns. The 29-kDa amino-terminal fibronectin fragment (29-kDa FN-f) is a matrix degradation product found in the synovial fluids of patients with osteoarthritis (OA). We investigated whether NOD2 was involved in 29-kDa FN-f-induced pro-catabolic gene expression in human chondrocytes. The expression of mRNA and protein was measured using quantitative real-time polymerase chain reaction (qrt-PCR) and Western blot analysis. Small interfering RNAs were used for knockdown of NOD2 and toll-like receptor 2 (TLR-2). An immunoprecipitation assay was performed to examine protein interactions. The NOD2 levels in human OA cartilage were much higher than in normal cartilage. NOD1 and NOD2 expression, as well as pro-inflammatory cytokines, including interleukin-1beta (IL-$1{\beta}$) and tumor necrosis factor-alpha (TNF-${\alpha}$), were upregulated by 29-kDa FN-f in human chondrocytes. NOD2 silencing showed that NOD2 was involved in the 29-kDa FN-f-induced expression of TLR-2. Expressions of IL-6, IL-8, matrix metalloproteinase (MMP)-1, -3, and -13 were also suppressed by TLR-2 knockdown. Furthermore, NOD2 and TLR-2 knockdown data demonstrated that both NOD2 and TLR-2 modulated the expressions of their adaptors, receptorinteracting protein 2 (RIP2) and myeloid differentiation 88, in 29-kDa FN-f-treated chondrocytes. 29-kDa FN-f enhanced the interaction of NOD2, RIP2 and transforming growth factor beta-activated kinase 1 (TAK1), an indispensable signaling intermediate in the TLR-2 signaling pathway, and activated nuclear factor-${\kappa}B$ (NF-${\kappa}B$), subsequently leading to increased expressions of pro-inflammatory cytokines and cartilage-degrading enzymes. These results demonstrate that 29-kDa FN-f modulated pro-catabolic responses via cross-regulation of NOD2 and TLR-2 signaling pathways.

Keywords

References

  1. Felson DT (2006) Clinical practice. Osteoarthritis of the knee. N Engl J Med 354, 841-848 https://doi.org/10.1056/NEJMcp051726
  2. Goldring MB (2000) The role of the chondrocyte in osteoarthritis. Arthritis Rheum 43, 1916-1926 https://doi.org/10.1002/1529-0131(200009)43:9<1916::AID-ANR2>3.0.CO;2-I
  3. Kim HA, Cho ML, Choi HY et al (2006) The catabolic pathway mediated by Toll-like receptors in human osteoarthritic chondrocytes. Arthritis Rheum 54, 2152-2163 https://doi.org/10.1002/art.21951
  4. Xie DL, Meyers R and Homandberg GA (1992) Fibronectin fragments in osteoarthritic synovial fluid. J Rheumatol 19, 1448-1452
  5. Homandberg GA and Hui F (1996) Association of proteoglycan degradation with catabolic cytokine and stromelysin release from cartilage cultured with fibronectin fragments. Arch Biochem Biophys 334, 325-331 https://doi.org/10.1006/abbi.1996.0461
  6. Pichika R and Homandberg GA (2004) Fibronectin fragments elevate nitric oxide (NO) and inducible NO synthetase (iNOS) levels in bovine cartilage and iNOS inhibitors block fibronectin fragment mediated damage and promote repair. Inflamm Res 53, 405-412 https://doi.org/10.1007/s00011-004-1279-8
  7. Wu J, Zhang Y, Xin Z and Wu X (2015) The crosstalk between TLR2 and NOD2 in Aspergillus fumigatus keratitis. Mol Immunol 64, 235-243 https://doi.org/10.1016/j.molimm.2014.11.021
  8. Ko R and Lee SY (2016) Glycogen synthase kinase 3beta in Toll-like receptor signaling. BMB Rep 49, 305-310 https://doi.org/10.5483/BMBRep.2016.49.6.059
  9. Basu M, Paichha M, Swain B et al (2015) Modulation of TLR2, TLR4, TLR5, NOD1 and NOD2 receptor gene expressions and their downstream signaling molecules following thermal stress in the Indian major carp catla (Catla catla). 3 Biotech 5, 1021-1030 https://doi.org/10.1007/s13205-015-0306-5
  10. Seong SY and Matzinger P (2004) Hydrophobicity: an ancient damage-associated molecular pattern that initiates innate immune responses. Nat Rev Immunol 4, 469-478 https://doi.org/10.1038/nri1372
  11. Hwang HS, Park SJ, Cheon EJ, Lee MH and Kim HA (2015) Fibronectin fragment-induced expression of matrix metalloproteinases is mediated by MyD88-dependent TLR-2 signaling pathway in human chondrocytes. Arthritis Res Ther 17, 320 https://doi.org/10.1186/s13075-015-0833-9
  12. Xu J, Jiang C, Zhu W et al (2015) NOD2 pathway via RIPK2 and TBK1 is involved in the aberrant catabolism induced by T-2 toxin in chondrocytes. Osteoarthritis Cartilage 23, 1575-1585 https://doi.org/10.1016/j.joca.2015.04.016
  13. Su SL, Yang HY, Lee CH, Huang GS, Salter DM and Lee HS (2012) The (-1486T/C) promoter polymorphism of the TLR-9 gene is associated with end-stage knee osteoarthritis in a Chinese population. J Orthop Res 30, 9-14 https://doi.org/10.1002/jor.21494
  14. Yang HY, Lee HS, Lee CH et al (2013) Association of a functional polymorphism in the promoter region of TLR-3 with osteoarthritis: a two-stage case-control study. J Orthop Res 31, 680-685 https://doi.org/10.1002/jor.22291
  15. Scanzello CR and Goldring SR (2012) The role of synovitis in osteoarthritis pathogenesis. Bone 51, 249-257 https://doi.org/10.1016/j.bone.2012.02.012
  16. Hasegawa M, Fujimoto Y, Lucas PC et al (2008) A critical role of RICK/RIP2 polyubiquitination in Nod-induced NF-kappaB activation. EMBO J 27, 373-383 https://doi.org/10.1038/sj.emboj.7601962
  17. Borzutzky A, Fried A, Chou J, Bonilla FA, Kim S and Dedeoglu F (2010) NOD2-associated diseases: Bridging innate immunity and autoinflammation. Clin Immunol 134, 251-261 https://doi.org/10.1016/j.clim.2009.05.005
  18. Elia PP, Tolentino YF, Bernardazzi C and de Souza HS (2015) The role of innate immunity receptors in the pathogenesis of inflammatory bowel disease. Mediators Inflamm 2015, 936193 https://doi.org/10.1155/2015/936193
  19. Kim H, Lee YD, Kim MK et al (2017) Extracellular S100A4 negatively regulates osteoblast function by activating the NF-kappaB pathway. BMB Rep 50, 97-102 https://doi.org/10.5483/BMBRep.2017.50.2.170
  20. Boyle JP, Parkhouse R and Monie TP (2014) Insights into the molecular basis of the NOD2 signalling pathway. Open Biol 4, 140178 https://doi.org/10.1098/rsob.140178
  21. Zack MD, Arner EC, Anglin CP, Alston JT, Malfait AM and Tortorella MD (2006) Identification of fibronectin neoepitopes present in human osteoarthritic cartilage. Arthritis Rheum 54, 2912-2922 https://doi.org/10.1002/art.22045
  22. Fosang AJ, Last K, Gardiner P, Jackson DC and Brown L (1995) Development of a cleavage-site-specific monoclonal antibody for detecting metalloproteinase-derived aggrecan fragments: detection of fragments in human synovial fluids. Biochem J 310 ( Pt 1), 337-343 https://doi.org/10.1042/bj3100337
  23. Lees S, Golub SB, Last K et al (2015) Bioactivity in an Aggrecan 32-mer Fragment Is Mediated via Toll-like Receptor 2. Arthritis Rheumatol 67, 1240-1249 https://doi.org/10.1002/art.39063
  24. Miller RE, Ishihara S, Tran PB et al (2018) An aggrecan fragment drives osteoarthritis pain through Toll-like receptor 2. JCI Insight 3, e95704 https://doi.org/10.1172/jci.insight.95704
  25. Strober W, Murray PJ, Kitani A and Watanabe T (2006) Signalling pathways and molecular interactions of NOD1 and NOD2. Nat Rev Immunol 6, 9-20 https://doi.org/10.1038/nri1747
  26. Joosten LA, Heinhuis B, Abdollahi-Roodsaz S et al (2008) Differential function of the NACHT-LRR (NLR) members Nod1 and Nod2 in arthritis. Proc Natl Acad Sci U S A 105, 9017-9022 https://doi.org/10.1073/pnas.0710445105
  27. Vieira SM, Cunha TM, Franca RF et al (2012) Joint NOD2/RIPK2 signaling regulates IL-17 axis and contributes to the development of experimental arthritis. J Immunol 188, 5116-5122 https://doi.org/10.4049/jimmunol.1004190
  28. Heinhuis B, Koenders MI, van de Loo FA et al (2010) IL-32gamma and Streptococcus pyogenes cell wall fragments synergise for IL-1-dependent destructive arthritis via upregulation of TLR-2 and NOD2. Ann Rheum Dis 69, 1866-1872 https://doi.org/10.1136/ard.2009.127399
  29. Watanabe T, Kitani A, Murray PJ and Strober W (2004) NOD2 is a negative regulator of Toll-like receptor 2-mediated T helper type 1 responses. Nat Immunol 5, 800-808 https://doi.org/10.1038/ni1092
  30. Netea MG, Ferwerda G, de Jong DJ et al (2005) Nucleotide-binding oligomerization domain-2 modulates specific TLR pathways for the induction of cytokine release. J Immunol 174, 6518-6523 https://doi.org/10.4049/jimmunol.174.10.6518
  31. Kim JR, Yoo JJ and Kim HA (2018) Therapeutics in Osteoarthritis Based on an Understanding of Its Molecular Pathogenesis. Int J Mol Sci 19, 674 https://doi.org/10.3390/ijms19030674
  32. Kapoor M, Martel-Pelletier J, Lajeunesse D, Pelletier JP and Fahmi H (2011) Role of proinflammatory cytokines in the pathophysiology of osteoarthritis. Nat Rev Rheumatol 7, 33-42 https://doi.org/10.1038/nrrheum.2010.196
  33. van de Loo FA, Kuiper S, van Enckevort FH, Arntz OJ and van den Berg WB (1997) Interleukin-6 reduces cartilage destruction during experimental arthritis. A study in interleukin-6-deficient mice. Am J Pathol 151, 177-191
  34. Ospelt C, Brentano F, Jungel A et al (2009) Expression, regulation, and signaling of the pattern-recognition receptor nucleotide-binding oligomerization domain 2 in rheumatoid arthritis synovial fibroblasts. Arthritis Rheum 60, 355-363 https://doi.org/10.1002/art.24226
  35. Petterson T, Jendholm J, Mansson A, Bjartell A, Riesbeck K and Cardell LO (2011) Effects of NOD-like receptors in human B lymphocytes and crosstalk between NOD1/NOD2 and Toll-like receptors. J Leukoc Biol 89, 177-187 https://doi.org/10.1189/jlb.0210061
  36. Chen G, Shaw MH, Kim YG and Nunez G (2009) NOD-like receptors: role in innate immunity and inflammatory disease. Annu Rev Pathol 4, 365-398 https://doi.org/10.1146/annurev.pathol.4.110807.092239